Lanreotide and octreotide complexed with technetium-99m: labeling, stability and biodistribution studies
RBCF, Rev. bras. ciênc. farm. (Impr.)
;
40(1): 101-110, jan.-mar. 2004. ilus, tab, graf
Article
Dans Anglais
| LILACS
| ID: lil-391018
ABSTRACT
Lanreotide and Octreotide are cyclic octapeptide analogues of somatostatin that were labeled with the radioisotope Technetium-99m for use in diagnostic nuclear medicine. The peptides were processed in a tartrate/phthalate buffer solution containing reducing agent. The purpose of this investigation was to optimize direct labeling by varying some parameters, and to evaluate radiochemical stability and biodistribution in animals. The marked peptides were obtained with high labeling efficiency and no need for subsequent purification. best radiolabeling results corresponded to a molar ratio of SnCl2.H2O/peptide of 4.5. `ANTPOT. 99mTc'-peptides were radiochemically stable for 6 hours...
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Peptides
/
Octréotide
/
Technétium
/
Médecine nucléaire
langue:
Anglais
Texte intégral:
RBCF, Rev. bras. ciênc. farm. (Impr.)
Thème du journal:
Biochimie
/
Pharmacie
/
Pharmacologie
Année:
2004
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Instituto de Pesquisas Energéticas e Nucleares/BR
/
Universidade Federal de São Paulo/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS